273 related articles for article (PubMed ID: 7752758)
1. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
[TBL] [Abstract][Full Text] [Related]
3. Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys.
Walther-Jallow L; Nilsson C; Söderlund J; Ten Haaft P; Mäkitalo B; Biberfeld P; Böttiger P; Heeney J; Biberfeld G; Thorstensson R
J Gen Virol; 2001 Jul; 82(Pt 7):1601-1612. PubMed ID: 11413371
[TBL] [Abstract][Full Text] [Related]
4. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'.
Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.
Titti F; Sernicola L; Geraci A; Panzini G; Di Fabio S; Belli R; Monardo F; Borsetti A; Maggiorella MT; Koanga-Mogtomo M; Corrias F; Zamarchi R; Amadori A; Chieco-Bianchi L; Verani P
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2529-39. PubMed ID: 9349474
[TBL] [Abstract][Full Text] [Related]
6. An attenuated vaccine for AIDS?
Beale J
Lancet; 1995 May; 345(8961):1318-9. PubMed ID: 7752750
[TBL] [Abstract][Full Text] [Related]
7. Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.
Berry N; Ham C; Mee ET; Rose NJ; Mattiuzzo G; Jenkins A; Page M; Elsley W; Robinson M; Smith D; Ferguson D; Towers G; Almond N; Stebbings R
PLoS One; 2011; 6(8):e23092. PubMed ID: 21853072
[TBL] [Abstract][Full Text] [Related]
8. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
[TBL] [Abstract][Full Text] [Related]
9. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus.
Letvin NL; Li J; Halloran M; Cranage MP; Rud EW; Sodroski J
J Virol; 1995 Jul; 69(7):4569-71. PubMed ID: 7769725
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells.
Almond N; Corcoran T; Hull R; Walker B; Rose J; Sangster R; Silvera K; Silvera P; Cranage M; Rud E; Stott EJ
J Med Primatol; 1997; 26(1-2):34-43. PubMed ID: 9271187
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated simian immunodeficiency virus vaccination confers superinfection resistance against macrophage-tropic and neurovirulent wild-type SIV challenge.
Berry N; Ham C; Alden J; Clarke S; Stebbings R; Stott J; Ferguson D; Almond N
J Gen Virol; 2015 Jul; 96(Pt 7):1918-29. PubMed ID: 25834093
[TBL] [Abstract][Full Text] [Related]
16. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8).
Berry N; Stebbings R; Ferguson D; Ham C; Alden J; Brown S; Jenkins A; Lines J; Duffy L; Davis L; Elsley W; Page M; Hull R; Stott J; Almond N
J Gen Virol; 2008 Sep; 89(Pt 9):2240-2251. PubMed ID: 18753233
[TBL] [Abstract][Full Text] [Related]
17. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
Wyand MS; Manson K; Montefiori DC; Lifson JD; Johnson RP; Desrosiers RC
J Virol; 1999 Oct; 73(10):8356-63. PubMed ID: 10482586
[TBL] [Abstract][Full Text] [Related]
18. A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
Amara RR; Patel K; Niedziela G; Nigam P; Sharma S; Staprans SI; Montefiori DC; Chenareddi L; Herndon JG; Robinson HL; McClure HM; Novembre FJ
J Virol; 2005 Dec; 79(24):15356-67. PubMed ID: 16306607
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
Daniel MD; Kirchhoff F; Czajak SC; Sehgal PK; Desrosiers RC
Science; 1992 Dec; 258(5090):1938-41. PubMed ID: 1470917
[TBL] [Abstract][Full Text] [Related]
20. Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.
Blancou P; Chenciner N; Ho Tsong Fang R; Monceaux V; Cumont MC; Guétard D; Hurtrel B; Wain-Hobson S
J Virol; 2004 Feb; 78(3):1080-92. PubMed ID: 14722263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
